.jpg)
The 3rd International Online Conference on Genes
Abstract Submission Deadline Extension.
Upon receiving requests from a few authors to extend the abstract submission deadline, we are delighted to extend it to 4 September 2026.
Instructions for authors are available online.
Submit your abstracts HERE.
For any inquiries, please contact us at iocge2026@mdpi.com.
the chair
Dear Colleagues,
We are delighted to announce the 3rd International Online Conference on Genes (IOCGE 2026), organized by the open-access journal Genes (ISSN: 2073-4425; Impact Factor: 3.1) and published by MDPI. The conference will be held virtually from 2–4 December 2026.
Building on the success of previous editions, IOCGE 2026 will once again serve as a dynamic global forum for scientists and researchers to share their latest discoveries, foster collaborations, and engage in stimulating discussions on the most pressing topics in genetics.
The scientific program will feature sessions spanning the breadth and depth of the field, including the following:
This event offers a unique opportunity to present novel findings, exchange innovative methodologies, and explore the latest breakthroughs transforming our understanding of genes and their role in health and disease. By bringing together leading experts, early-career scientists, and practitioners worldwide, IOCGE 2026 aims to promote interdisciplinary dialogue and inspire new avenues for both basic research and clinical translation.
All accepted abstracts will be published online on Sciforum.net, ensuring broad visibility and lasting impact.
We warmly invite you to be part of IOCGE 2026 and look forward to your contributions to this exciting scientific exchange.
Download the conference flyer and share it with your colleagues!
Kind regards,
Prof. Selvarangan Ponnazhagan
The University of Alabama at Birmingham, USA
Follow the conference organizer on Social Media
Flyers
- 24CONF-IOCGE 2026-Flyer-A5-Web-1.pdf
Important Dates
- Abstract submission deadlineSep 04, 2026
- Abstract acceptance notificationSep 30, 2026
- Registration end dateNov 26, 2026
Meet Our Speakers
Unit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy;
Silvia Turroni is Associate Professor in Chemistry and Biotechnology of Fermentation, at the Unit of Microbiome Science and Biotechnology, Dept. Pharmacy and Biotechnology, University of Bologna (Bologna, Italy). She has over 15 years of experience in the compositional and functional profiling of the human microbiome and the exploration of its impact on health. She has strong expertise in next-generation sequencing technologies, including 16S rRNA gene sequencing and omics approaches, i.e., metagenomics, metatranscriptomics and, more recently, culturomics, as well as in microbiome-host interaction studies in ex vivo models.
Rollins School of Public Health, Emory University, Atlanta, USA;
Dr. Qin has 20 years of independent research experience in Biostatistics and Bioinformatics. His research covers Bioinformatics, Biostatistics, Statistical Genetics as well as Computational Biology. Recently, his research expanded to include Machine Learning, AI, Big Data Analytics, and their applications to translational and precision medicine. Dr. Qin actively collaborates with basic scientists and clinicians, contributing to the understanding of the biological mechanisms underlying cancer and complex diseases.
University of California, Los Angeles (UCLA), Los Angeles, USA;
Dr. Yang is currently Professor in the Department of Integrative Biology and Physiology and Department of Molecular and Medical Pharmacology at UCLA. She serves as the Vice Chair of the Molecular, Cellular, and Integrative Physiology Ph.D. program and the Vice Chair of the Computational & Systems Biology Undergraduate Program. Her lab specializes in developing computational tools to integrate multiomics data (genetic, transcriptome, epigenome, proteome, metabolome, and microbiome) and model multitissue multiomics networks underlying complex traits such as sex differences and diseases such as cardiometabolic and brain disorders. Her experiences in both industry (Senior Research Scientist at Rosetta Inpharmatics/Merck & Co) and academia (Principal Scientist and Director of Systems Biology at Sage Bionetworks; faculty at UCLA) enable a broad research portfolio from computational tool development to disease mechanism investigations to drug discovery using multiomics computational approaches.
Center for Molecular Medicine and Genetics, Department of Pathology and Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA;
Dr. Heng proposed the Genome Architecture Theory, a new conceptual framework for genomics and evolution, which led to the platforms to study chromosomal instability in cancer. He is the author of Debating Cancer: The Paradox in Cancer Research and Genome Chaos: Rethinking Genetics, Evolution, and Molecular Medicine. He discovered the two-phased evolution, which departs from the traditional gradual Darwinian model, and demonstrated that genome chaos plays a critical role in information self-creation through large-scale genome reorganization. His concept of karyotype coding—representing system-level inheritance—stands in contrast to gene-based, part-level inheritance and provides a new perspective for pharmacogenomics. In cancer, genome instability and karyotype-level evolution contribute to rapid drug resistance, underscoring the need to study evolution-based mechanisms to guide future pharmacogenomics. (PMID: 31737054; PMID: 34195196; PMID: 39273111).
